Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 4, 1997, Pages 533-536

  Hamroff, Glenn ^a,c,d   Blaufarb, Ira ^a,b,c   Mancini, Donna ^a,b,c   Katz, Stuart D ^a,b   Bijou, Rachel ^a,b   Jondeau, Guillaume ^a,b   Olivari, Maria Teresa ^a,b   Thomas, Sylvia ^a,b   Lejemtel, Thierry H ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Orthopaedic Surgery   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Angiotensin; Blood pressure; Heart failure; Renin

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; LOSARTAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDICATION; DRUG SAFETY; DRUG TOLERANCE; ENZYME INHIBITION; HEART AFTERLOAD; HEART FAILURE; HUMAN; PRIORITY JOURNAL; RANDOMIZATION; SYMPTOMATOLOGY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; RECEPTORS, ANGIOTENSIN;

EID: 0030658003     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199710000-00020     Document Type: Article

References (7)

1. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983;2:755-63.
2. van den Meiracker AH, Man in't Veld AJ, Admiraal PJJ, et al. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992;10:803-12.
3. Schunkert H, Ingelfinger JR, Hirsch AT, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-8.
4. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin H-forming pathways in normal and failing human hearts. Ci/rfs1990;66:883-90.
5. Azizi M, Chatellier G, Guyene T-T, Murieta-Geoffroy D, Menard J. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92: 825-34.
6. Pontieri V, Lopes OU, Ferreira SH. Hypotensive effect of captopril: role of bradykinin and prostaglandinlike substances. Hypertension I990;15(suppl I):I55-8.
7. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-54.